New Guidelines Ease Judicial Burden for Pharma Firms
Published on: Jan. 5, 2026, 7:27 p.m. | Source: Devdiscourse
Amended guidelines now allow pharmaceutical firms to avoid court appearances for minor offences by paying a monetary penalty and making self-corrective actions, under the Drugs and Cosmetics (Compounding of Offences) Rules, 2025. This change, part of the Jan Vishwas Act, aims to ease business processes.
